In enzymatically isolated ventricular cardiomyocytes from rat and guin
ea pig, adenosine (ADO) reduced the basal (non-beta-adrenergically sti
mulated) L-type Ca2+-current (I-Ca) from 11 +/- 2.1 mu A/cm(2) to 3.1
+/- 0.7 mu A/cm(2) in a dose-dependent manner (K-D = 10 nM). Simultane
ously, the free intracellular Ca2+ concentration [Ca2+](i) was elevate
d from 100 +/- 15 nM to 1,800 +/- 400 nM. Similar effects were observe
d with the ADO-Al-receptor agonist N-6-cyclopentyladenosine. The ADO e
ffects were fully suppressed by the Al-receptor antagonist 8-cyclopent
yl-1,3-dipropylxanthin while the synthetic ADO-Az-receptor agonist CGS
-21680 affected neither I-Ca nor [Ca2+](i). The inhibition of Ic, and
the increase in [Ca2+](i) were not abolished by pretreating the cells
with pertussis toxin 5 mu g/ml/37 degrees C/300 min, but GDP beta S (1
0 mu M) reduced the effects of ADO by 86.7 +/- 7%. Application of ryan
odine thapsigargin 0.1 mu M, the Ca2+-chelator (0.1-10 mM) and low-mol
ecular weight heparin (50mg/ml) suppressed the ADO-evoked responses wh
ile intracellular application of 50 mu M inositol 1,4,5-trisphosphate
(IP3) and its non-hydrolyzable analogue IPS3 (10 mu M) mimicked the AD
O effects. The results suggest that the inhibition of basal Ica by ADO
occurs via stimulation of phospholipase C followed by IP3-induced int
racellular Ca2+ release.